MktsMarkets

Crinetics Pharmaceuticals, Inc.
NASDAQ: CRNXKey statistics
CRNX News
Stories mentioning CRNX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 10,734 | 6,161 | 143.00 | 1,031 | 361.00 | 0.00 | 0.00 | 399.00 |
| Cost of Goods Sold | 200.00 | 0.00 | ||||||
| Gross Profit | 10,534 | 361.00 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 100,081 | 85,053 | 90,464 | 80,301 | 76,240 | 66,566 | 61,905 | 58,344 |
| Sales General & Admin | 49,842 | 35,526 | 24,838 | |||||
| Total Operating Expenses | 142,729 | 130,143 | 111,766 | 94,745 | 87,797 | 83,182 | ||
| Operating Income (Loss) | (140,378) | (133,666) | (142,586) | (129,112) | (111,405) | (94,745) | (87,797) | (82,783) |
| Interest Income | 12,664 | 11,156 | 12,544 | 13,455 | 14,834 | 14,368 | 11,006 | 8,741 |
| Interest Expense | ||||||||
| Other Expense | (131.00) | (49.00) | (203.00) | (37.00) | ||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (127,845) | (122,815) | (130,091) | (115,637) | (96,774) | (80,595) | (76,828) | (74,055) |
| Earnings Per Share (Basic) | (1.23) | (1.31) | (1.38) | (1.23) | (1.04) | (1.00) | (0.96) | (0.94) |
| Earnings Per Share (Diluted) | (1.23) | (1.31) | (1.38) | (1.23) | (1.04) | (1.00) | (0.96) | (0.94) |
| Weighted Average Shares Outstanding (Basic) | 104,099 | 94,057 | 94,215 | 93,791 | 93,102 | 80,783 | 80,091 | 79,008 |
| Weighted Average Shares Outstanding (Diluted) | 104,099 | 94,057 | 94,215 | 93,791 | 93,102 | 80,783 | 80,091 | 79,008 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRNX
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRNX. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET), up 0.1% on the day. That gives Crinetics Pharmaceuticals a market capitalisation of $9.0B.
Over the past 52 weeks CRNX has traded between $32.30 and $85.01.
Revenue for the quarter ended Mar 31, 2026 was $10.7M; a net loss of $127.8M. Revenue was up 2873% from $361.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $10.7M | -$127.8M | -1191.0% |
| Dec 31, 2025 | $6.2M | -$122.8M | -1993.4% |
| Sep 30, 2025 | $143.0K | -$130.1M | -90972.7% |
| Jun 30, 2025 | $1.0M | -$115.6M | -11216.0% |
From Crinetics Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…